These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 37874348)
41. Silencing of Long Noncoding RNA SNHG6 Inhibits Esophageal Squamous Cell Carcinoma Progression via miR-186-5p/HIF1α Axis. Du F; Guo T; Cao C Dig Dis Sci; 2020 Oct; 65(10):2844-2852. PubMed ID: 31853782 [TBL] [Abstract][Full Text] [Related]
42. RAC1 inhibition reverses cisplatin resistance in esophageal squamous cell carcinoma and induces downregulation of glycolytic enzymes. Zeng RJ; Zheng CW; Gu JE; Zhang HX; Xie L; Xu LY; Li EM Mol Oncol; 2019 Sep; 13(9):2010-2030. PubMed ID: 31314174 [TBL] [Abstract][Full Text] [Related]
43. Targeting glutamine-addiction and overcoming CDK4/6 inhibitor resistance in human esophageal squamous cell carcinoma. Qie S; Yoshida A; Parnham S; Oleinik N; Beeson GC; Beeson CC; Ogretmen B; Bass AJ; Wong KK; Rustgi AK; Diehl JA Nat Commun; 2019 Mar; 10(1):1296. PubMed ID: 30899002 [TBL] [Abstract][Full Text] [Related]
44. CircDUSP16 Contributes to Cell Development in Esophageal Squamous Cell Carcinoma by Regulating miR-497-5p/TKTL1 Axis. Ma L; Li H; Lin Y; Wang G; Xu Q; Chen Y; Xiao K; Rao X J Surg Res; 2021 Apr; 260():64-75. PubMed ID: 33326930 [TBL] [Abstract][Full Text] [Related]
45. [Expression and significance of FoxM1 in esophageal squamous cell carcinoma cells in vitro and in vivo]. Gai L; Mao GX; Liu J; Huang H; Wang X; Yao NH Zhonghua Zhong Liu Za Zhi; 2016 Mar; 38(3):179-84. PubMed ID: 26988822 [TBL] [Abstract][Full Text] [Related]
46. EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition. Sato F; Kubota Y; Natsuizaka M; Maehara O; Hatanaka Y; Marukawa K; Terashita K; Suda G; Ohnishi S; Shimizu Y; Komatsu Y; Ohashi S; Kagawa S; Kinugasa H; Whelan KA; Nakagawa H; Sakamoto N Cancer Biol Ther; 2015; 16(6):933-40. PubMed ID: 25897987 [TBL] [Abstract][Full Text] [Related]
47. MTA1 promotes tumorigenesis and development of esophageal squamous cell carcinoma via activating the MEK/ERK/p90RSK signaling pathway. Nan P; Wang T; Li C; Li H; Wang J; Zhang J; Dou N; Zhan Q; Ma F; Wang H; Qian H Carcinogenesis; 2020 Sep; 41(9):1263-1272. PubMed ID: 31783401 [TBL] [Abstract][Full Text] [Related]
48. ANXA2 promotes esophageal cancer progression by activating MYC-HIF1A-VEGF axis. Ma S; Lu CC; Yang LY; Wang JJ; Wang BS; Cai HQ; Hao JJ; Xu X; Cai Y; Zhang Y; Wang MR J Exp Clin Cancer Res; 2018 Aug; 37(1):183. PubMed ID: 30081903 [TBL] [Abstract][Full Text] [Related]
49. Long noncoding RNA H19 is up-regulated in esophageal squamous cell carcinoma and promotes cell proliferation and metastasis. Tan D; Wu Y; Hu L; He P; Xiong G; Bai Y; Yang K Dis Esophagus; 2017 Jan; 30(1):1-9. PubMed ID: 27247022 [TBL] [Abstract][Full Text] [Related]
50. NIR-II Navigation with an EGFR-Targeted Probe Improves Imaging Resolution and Sensitivity of Detecting Micrometastases in Esophageal Squamous Cell Carcinoma Xenograft Models. Wang L; Liang M; Xiao Y; Chen J; Mei C; Lin Y; Zhang Y; Li D Mol Pharm; 2022 Oct; 19(10):3563-3575. PubMed ID: 35420035 [TBL] [Abstract][Full Text] [Related]
51. Epigenetically upregulated oncoprotein PLCE1 drives esophageal carcinoma angiogenesis and proliferation via activating the PI-PLCε-NF-κB signaling pathway and VEGF-C/ Bcl-2 expression. Chen Y; Wang D; Peng H; Chen X; Han X; Yu J; Wang W; Liang L; Liu Z; Zheng Y; Hu J; Yang L; Li J; Zhou H; Cui X; Li F Mol Cancer; 2019 Jan; 18(1):1. PubMed ID: 30609930 [TBL] [Abstract][Full Text] [Related]
52. Long non‑coding RNA BANCR promotes proliferation, invasion and migration in esophageal squamous cell carcinoma cells via the Raf/MEK/ERK signaling pathway. Yu X; Huang M; Yang G Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880577 [TBL] [Abstract][Full Text] [Related]
53. RIT1 suppresses esophageal squamous cell carcinoma growth and metastasis and predicts good prognosis. Feng YF; Lei YY; Lu JB; Xi SY; Zhang Y; Huang QT; Wu QL; Wang F Cell Death Dis; 2018 Oct; 9(11):1085. PubMed ID: 30348939 [TBL] [Abstract][Full Text] [Related]
54. A novel long noncoding RNA, LOC440173, promotes the progression of esophageal squamous cell carcinoma by modulating the miR-30d-5p/HDAC9 axis and the epithelial-mesenchymal transition. Wang G; Feng B; Niu Y; Wu J; Yang Y; Shen S; Guo Y; Liang J; Guo W; Dong Z Mol Carcinog; 2020 Dec; 59(12):1392-1408. PubMed ID: 33079409 [TBL] [Abstract][Full Text] [Related]
55. miR-133a-3p suppresses cell proliferation, migration, and invasion and promotes apoptosis in esophageal squamous cell carcinoma. Yin Y; Du L; Li X; Zhang X; Gao Y J Cell Physiol; 2019 Aug; 234(8):12757-12770. PubMed ID: 30537034 [TBL] [Abstract][Full Text] [Related]
56. Tumor Cell-Derived Complement Component C1r Acts as a Prognostic Biomarker and Promotes Esophageal Squamous Cell Carcinoma Progression. Tang M; Zhao S; Ren L; Li Q; Li L; Wang C; Meng C; Chen Y; Hu W Front Biosci (Landmark Ed); 2024 Apr; 29(4):138. PubMed ID: 38682192 [TBL] [Abstract][Full Text] [Related]
57. FOXD3 suppresses epithelial-mesenchymal transition through direct transcriptional promotion of SMAD7 in esophageal squamous cell carcinoma. Wu Z; Li Y; Niu Y; Lu J; Yan Z; Xu T; Guo Y; Dong Z; Guo W Mol Carcinog; 2021 Dec; 60(12):859-873. PubMed ID: 34551139 [TBL] [Abstract][Full Text] [Related]
58. miR-25 mediates metastasis and epithelial-mesenchymal-transition in human esophageal squamous cell carcinoma via regulation of E-cadherin signaling. Liu B; Li X; Li C; Xu R; Sun X Bioengineered; 2019 Dec; 10(1):679-688. PubMed ID: 31679450 [TBL] [Abstract][Full Text] [Related]
59. SOX12 contributes to the activation of the JAK2/STAT3 pathway and malignant transformation of esophageal squamous cell carcinoma. Li C; Zhu M; Zhu J; Lu Q; Shi B; Sun B; Chen H Oncol Rep; 2021 Jan; 45(1):129-138. PubMed ID: 33416144 [TBL] [Abstract][Full Text] [Related]
60. [Expression of microRNA-17-5p in esophageal squamous cell carcinoma and its effects on cell proliferation and invasion]. Xu H; Meng XR; Zhou Y; Wang F Zhonghua Zhong Liu Za Zhi; 2020 Feb; 42(2):105-113. PubMed ID: 32135643 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]